Enhancing parental knowledge about vaccine science is one strategy for promoting vaccination adherence and overcoming vaccine hesitancy. An alternative approach is to target school-aged children as they are the parents of the future.
Egg allergies are no longer a contraindication for influenza vaccination, but intranasal mists won’t be an alternative for the shot during this year’s flu season, either, according to new recommendations released by the American Academy of Pediatrics.
Recent data has revealed the live attenuated influenza vaccine (LAIV), also known as the “nasal spray” vaccine, to be grossly ineffective, leading to the ACIP’s decision not to recommend its usage. As such, healthcare providers must be judicious in their choice of influenza vaccine with their patients.
Maintaining the currently recommended vaccination schedule of influenza, pneumococcal conjugate, and diphtheria/tetanus/acellular pertussis vaccines in young children as put forth by the Centers for Disease Control and Prevention is likely the best way to manage immunization in this patient population despite the slightly increased risk for febrile seizure.
An analysis of data on the incidence of pertussis shows that although acellular pertussis (Tdap) vaccine had a positive impact among adolescents in the 4 years after it was introduced in 2005, in 2010 pertussis incidence in this age group began to increase more rapidly than it did in all other age groups.
For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a nationally representative survey published in Clinical Pediatrics. The survey asked parents what they wanted to know about vaccines and how they wanted providers to handle their concerns.